In summary, our study shows that RA significantly ameliorates systemic symptoms in a murine DSS-induced colitis model and suppresses expression of pro-inflammatory cytokines and inflammatory mediators through regulation of NF-κB and STAT3 activation. This evidence concerns the gene NFKB1 and colitis.